Virginia Commonwealth University
Live Cell Biomass Tracking for Basic, Translational, and Clinical Research
Abstract
dc:description.abstractSingle cell mass is tightly regulated throughout generations and the cell cycle, making it an important marker of cell health. Abnormal changes in cell size can be the first indication of dysfunction in response to environmental stimuli such as cytotoxic drugs. Described here is the further development of high-speed live cell interferometry (HSLCI) to concurrently measure the changes in single cell mass of thousands of cells over time. Critically, the high-throughput nature of HSLCI provides realistic pictures of tumor heterogeneity. This throughput enabled HSLCI to correctly predict in vivo carboplatin sensitivity of three triple negative breast cancer patient derived xenografts, while also characterizing the spectrum of drug response from apoptosis to senescence to drug resistance. HSLCI quantified previous qualitative observations of increases in cell size and losses in cell density in senescent cells, and importantly observed proliferative recovery in cells demonstrating thee senescent characteristics. Furthermore, the addition of a micropipette system has enabled the isolation of rare (~1%) drug resistant cells for further study with molecular biology methods. Together, this work highlights HSLCI’s versatility and potential for clinical, translational, and basic research.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Nanoscience and Nanotechnology
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Murray, Graeme
- <p>0000-0002-6503-9294</p>
- Contributors dc:contributor
-
- Jason Reed, PhD
- Joshua Harrell, PhD
- Loren Picco, PhD
- Amir Toor, MD
- Ross Mikkelsen, PhD
Subjects
dc:subject × 8Rights
dc:rights- Statement dc:rights
-
- © Graeme Murray
Identifiers
dc:identifier.*- Identifier
- https://scholarscompass.vcu.edu/etd/7129